We are so excited to welcome you in person in Heidelberg to this year's BioRN Annual Conference: "Novel therapeutics:Biotechnology leading the way into the future" on October 1.
Since 2009, each year the BioRN Annual Conference has been a valuable source of top information, lively discussions and networking opportunities with international experts from different fields of the life sciences.
This year Annual Conference presents some of these biotechnology-driven new therapeutical approaches and partnership models for successful drug development.
Keynotes
“Next generation Immunotherapy” by Holger Kissel, BioNTech SE, Vice President Business Alliances
“Development of Bulevirtide/Hepcludex®, the first approved medication to treat chronic Hepatitis D infections.” Florian Vogel, MYR (Gilead Sciences Inc.), Chief Commercial Officer and Stephan Urban, Heidelberg University Hospital, Head of the Translational Virology Unit Parallel Workshops, from Members to Members (by Cytiva, Cytel and M.Venture)
Speed-networking & Happy Hour
Poster Gallery - express here your interest for a poster!
We are thankful to all speakers for being at the heart of the meeting and accepting the invitation to share their exciting research.
We also would like to thank our sponsors for their dedication and financial support which allowed us to organize an excellent program.
You can also join the conference digitally. Register here.
Agenda
More Information
General Information about the event >>
Registration >>
Apply to present a poster >>
You are currently viewing a placeholder content from Mailchimp. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
